Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1992-1-16
|
pubmed:abstractText |
The separate and combined effects of successive administration of amantadine, 100 mg/kg, i.p., and chlorpromazine, 0.2 mg/kg, i.p., on motor activity and whole brain levels of certain biogenic amines and major metabolites were studied in four strains of mice. These were the albino ICR, the inbred BALB/C, C57BL/6 and the hybrid CDF-I mice. Amantadine produced a strain-dependent behavioral stimulation subsequent the fourth dose. This was apparent in ICR and C57BL/6 mouse strains and was followed by a behavioral depression phase occurring during the night in C57BL/6 mice which was antagonized by chlorpromazine. Administration of chlorpromazine alone affected only CDF-1 mouse mobility. Chlorpromazine reduced only ICR mouse brain dopamine without concomitant changes in major acid metabolites. Repeated administration of amantadine prior to chlorpromazine negated this effect. Chlorpromazine enhancement of BALB/C brain serotonin and 5-hydroxyindoleacetic acid was antagonised by pretreatment with amantadine. This antagonism was also evident in BALB/C mouse brain dihydroxyphenylacetic acid. The results suggest genotypic-dependent behavioral and cerebral effects by the drugs studied. The antagonism between amantadine and chlorpromazine on brain amines may explain the therapeutic efficacy of amantadine in modulating chlorpromazine-induced extrapyramidal disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0161-813X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
571-81
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1745440-Amantadine,
pubmed-meshheading:1745440-Animals,
pubmed-meshheading:1745440-Basal Ganglia Diseases,
pubmed-meshheading:1745440-Chlorpromazine,
pubmed-meshheading:1745440-Male,
pubmed-meshheading:1745440-Mice,
pubmed-meshheading:1745440-Mice, Inbred BALB C,
pubmed-meshheading:1745440-Mice, Inbred C57BL,
pubmed-meshheading:1745440-Mice, Inbred ICR,
pubmed-meshheading:1745440-Motor Activity,
pubmed-meshheading:1745440-Rats,
pubmed-meshheading:1745440-Rats, Inbred Strains,
pubmed-meshheading:1745440-Species Specificity
|
pubmed:year |
1991
|
pubmed:articleTitle |
Neurotoxicity of chlorpromazine and modulation by amantadine as a function of mouse strain.
|
pubmed:affiliation |
Department of Pharmacology, University of North Dakota School of Medicine, Grand Forks 58203.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|